Cargando…

A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets

CONTEXT: Although previous research has shown the benefit of continuous glucose monitoring (CGM) for hepatic glycogen storage diseases (GSDs), current lack of prospectively collected CGM metrics and glycemic targets for CGM-derived outcomes in the hepatic GSD population limits its use. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Alessandro, Venema, Annieke, Haarsma, Petra, Feldbrugge, Lude, Burghard, Rob, Rodriguez-Buritica, David, Parenti, Giancarlo, Oosterveer, Maaike H, Derks, Terry G J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387687/ https://www.ncbi.nlm.nih.gov/pubmed/35786777 http://dx.doi.org/10.1210/clinem/dgac411

Ejemplares similares

A retrospective in‐depth analysis of continuous glucose monitoring datasets for patients with hepatic glycogen storage disease: Recommended outcome parameters for glucose management
por: Peeks, Fabian, et al.
Publicado: (2021)

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
por: Peeks, Fabian, et al.
Publicado: (2017)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

Towards values‐based healthcare for inherited metabolic disorders: An overview of current practices for persons with liver glycogen storage disease and fatty acid oxidation disorders
por: Venema, Annieke, et al.
Publicado: (2022)

Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study
por: Grünert, Sarah C., et al.
Publicado: (2023)

Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
por: Derks, Terry G. J., et al.
Publicado: (2021)

High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia
por: Haring, Martijn P.D., et al.
Publicado: (2022)

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas
por: Moest, Wouter, et al.
Publicado: (2018)

Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia
por: Rossi, Alessandro, et al.
Publicado: (2023)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels
por: Saeed, Ali, et al.
Publicado: (2020)

Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring
por: Yapanis, Michael, et al.
Publicado: (2022)

A retrospective study of eating and psychosocial problems in patients with hepatic glycogen storage diseases and idiopathic ketotic hypoglycemia: Towards a standard set of patient‐reported outcome measures
por: Venema, Annieke, et al.
Publicado: (2021)

Geneotype and phenotype in 20 patients with glycogen storage disease type Ia
por: Liang, Cuili, et al.
Publicado: (2013)

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
por: Kruger, Eliza, et al.
Publicado: (2023)

Neurodevelopmental Disorders, Glycemic Control, and Diabetic Complications in Type 1 Diabetes: a Nationwide Cohort Study
por: Liu, Shengxin, et al.
Publicado: (2021)

Kinetics and Interrelations of the Renin Aldosterone Response to Acute Psychosocial Stress: A Neglected Stress System
por: Gideon, Angelina, et al.
Publicado: (2019)

Glycemic Control in Youth-onset Type 2 Diabetes: Predicting the Tomorrow Based on Lessons Learnt from TODAY
por: Pal, Rimesh, et al.
Publicado: (2022)

The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control
por: Yoshii, Hidenori, et al.
Publicado: (2022)

Response to Letter to the Editor from McKee and McGill: “Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring”
por: Juel, Caroline T B, et al.
Publicado: (2021)

A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia
por: Monteiro, Vaneisse C. L., et al.
Publicado: (2021)

Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
por: Rutten, Martijn G. S., et al.
Publicado: (2023)

A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring
por: Hoogeveen, Irene J., et al.
Publicado: (2018)

Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions
por: Derks, Terry G. J., et al.
Publicado: (2015)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia
por: Korljan Jelaska, Betty, et al.
Publicado: (2013)

Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
por: Farah, Benjamin L., et al.
Publicado: (2017)

The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS – ‘25 years of research through partnerships’
por: Kaleebu, P, et al.
Publicado: (2015)

Cognitive Function of Children and Adolescents With Congenital Adrenal Hyperplasia: Importance of Early Diagnosis
por: Messina, Valeria, et al.
Publicado: (2020)

Changes in orthodontics during the COVID-19 pandemic that have come to stay
por: García-Camba, Pablo, et al.
Publicado: (2020)

COVID-19: What do we know?
por: Marshall, Steve, et al.
Publicado: (2020)

Bridging worldviews: Toward a common model of leadership across the health professions
por: Garman, Andrew N., et al.
Publicado: (2020)

IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction
por: Joustra, Sjoerd D, et al.
Publicado: (2019)

Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma
por: Chortis, Vasileios, et al.
Publicado: (2019)

Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer
por: van Velsen, Evert F S, et al.
Publicado: (2019)

Bone Mineral Density After Transitioning From Denosumab to Alendronate
por: Kendler, David, et al.
Publicado: (2019)

Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry
por: Hugen, Niek, et al.
Publicado: (2019)

Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis
por: Zamanipoor Najafabadi, Amir H, et al.
Publicado: (2019)

Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender Youth
por: Nokoff, Natalie J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_srfj6ghbgrncgne12teaoogcvv